Literature DB >> 2573701

Solubilities of adenosine antagonists determined by radioreceptor assay.

R F Bruns1, J H Fergus.   

Abstract

The practical use of many adenosine receptor antagonists is limited by poor aqueous solubility. In some cases, solubilities are so low that they are difficult to measure by conventional means. To determine solubilities of adenosine antagonists, a sensitive radioreceptor method has been developed. Solubilities in Tris buffer (pH 7.7) ranged from 141 nM for 8-(2-amino-4-chlorophenyl)-1,3-dipropylxanthine to 945 microM for the amino-substituted xanthine PD 113,297. Ratios between solubility and adenosine receptor affinity varied from 15.8 for the A2-selective antagonist HTQZ to 169,000 for PD 113,297. From literature data on functional activity, it is apparent that useful adenosine antagonist activity in-vivo is only seen in compounds with solubility/affinity ratios greater than 100.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573701     DOI: 10.1111/j.2042-7158.1989.tb06537.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  Improvement of cold tolerance by selective A1 adenosine receptor antagonists in rats.

Authors:  T F Lee; D J Li; K A Jacobson; L C Wang
Journal:  Pharmacol Biochem Behav       Date:  1990-09       Impact factor: 3.533

Review 2.  Xanthines as adenosine receptor antagonists.

Authors:  Christa E Müller; Kenneth A Jacobson
Journal:  Handb Exp Pharmacol       Date:  2011

3.  Analysis of the atypical characteristics of adenosine receptors mediating negative inotropic and chronotropic responses of guinea-pig isolated atria and papillary muscles.

Authors:  N M Gardner; K J Broadley
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

4.  Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia.

Authors:  B A Finegan; G D Lopaschuk; M Gandhi; A S Clanachan
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

Review 5.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

Review 6.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

7.  Synthesis of Purine-Based Ionic Liquids and Their Applications.

Authors:  Ana R F Carreira; Telma Veloso; Nicolas Schaeffer; Joana L Pereira; Sónia P M Ventura; Cécile Rizzi; Juliette Sirieix Plénet; Helena Passos; João A P Coutinho
Journal:  Molecules       Date:  2021-11-18       Impact factor: 4.411

8.  Trifunctional agents as a design strategy for tailoring ligand properties: irreversible inhibitors of A1 adenosine receptors.

Authors:  D L Boring; X D Ji; J Zimmet; K E Taylor; G L Stiles; K A Jacobson
Journal:  Bioconjug Chem       Date:  1991 Mar-Apr       Impact factor: 4.774

Review 9.  Xanthine scaffold: scope and potential in drug development.

Authors:  Nivedita Singh; Ashwinee Kumar Shreshtha; M S Thakur; Sanjukta Patra
Journal:  Heliyon       Date:  2018-10-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.